Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Ho: Enhancing Innate Immune Activation |
| Strategy: | Combo: DNA & protein vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Mouse |
| Stage: | Assays Completed |
| Study Start Date: | 2009-02-25 |
| Study Made Public: | NA |
Title
Ho_Verhagen_Balb-c_mice1
Description
CAVD 301 is a preclinical mouse study to evaluate and compare the neutralization activity following peptide and DNA prime/boost regimens.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.